Scientific Discoveries
UT Southwestern metabolism faculty, their students, and their other lab members have made many key scientific discoveries. Here is a sampling of their discoveries:
Discovery | Scientist |
---|---|
2020 | |
Low dose Rosiglitazone + GPR120 agonist improves insulin sensitivity | Oh |
Prdm12 acts developmentally to program body weight homeostasis | C. Liu |
2019 | |
Nitrosative stress drives heart failure with preserved ejection fraction | J. Hill |
Ghrelin and LEAP2 are oppositely regulated by metabolic status | Zigman |
SCGN deficiency results in colitis susceptibility | Burstein |
Characterization of Kaufman oculocerebrofacial syndrome as a metabolic encephalomyopathy | Chahrour |
2018 | |
Flexibility of hypothalamic neurons/circuits in response to exercise | K. Williams |
Uromodulin regulates renal magnesium homeostasis | M. Wolf |
2016 | |
Metabolic heterogeneity in human cancers | DeBerardinis |
WNK1 inhibits autophagy | Cobb |
Discovery that Reelin and ApoE receptors regulate peripheral immune cell extravasation | Herz |
Adipose perivascular cells are developmental precursors of adipocytes formed in obesity | R. Gupta |
2015 | |
Schnyder corneal dystrophy (SCD)-associated mutations in UBIAD1 may facilitate accumulation of cholesterol | Debose-Boyd |
2014 | |
FGF21 is a starvation hormone that acts centrally to induce weight loss | Mangelsdorf and Kliewer |
Insig proteins affect intestinal cholesterol synthesis | Engelking |
2012 | |
Doxorubicin blocks cancer proliferation via stimulating ceramide synthesis | Ye |
2010 | |
Discovery that ApoE4 induces an endolysosomal trafficking defect | Herz |
2008 | |
Nuclear hormone receptor repertoire of pancreatic islets | Repa |
Identification of the first genetic factor for fatty liver disease | Cohen and Hobbs |
2006 | |
PCSK9 inactivation mutations lower LDL and prevent heart attacks | Horton, Cohen, Hobbs |
2005 | |
First large population-based study of prevalence of NAFLD (Dallas Heart Study) |
Browning, Horton, Grundy, Vega, Cohen, Hobbs |
Disruption of molecular circadian clock causes obesity | Takahashi |
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals | Towler |
2002 | |
Activation of central melanocortin pathways by the weight loss drug fenfluramine | Elmquist |
Leptin replacement therapy treats lipodystrophy | Garg |
2001 | |
ChREBP | Uyeda |
2000 | |
SIM1 deficiency causes profound obesity | Zinn |
1999 | |
Discovery of the Reelin receptors | Herz |
1998 | |
Alternate pathway of bile acid synthesis | Russell |
1995 | |
Adiponectin | Scherer |
1988 | |
Discovery of the LDL receptor-related protein (LRP) | Herz |
1974 | |
LDL receptor and genetic basis of familial hypercholesterolemia | Brown and Goldstein (1985 Nobel Prize) |
1969, 1978 | |
Roles of glucagon in glucose homeostasis and glucagon excess in diabetes | Unger |